"........... now discussing commercialization not weather or not Monepantel may work, or whether it will have adverse side effects etc. .........."
Absolutely Peet. Mt must really reckon he is holding the winning lotto ticket with this one. How often in ones career can you walk into an opportunity with this realizable potential. Drug production already (pretty much) complete, very low bar regards improving market position, major industry (MND), support with a strong advisor group to assist plus a long line of treatment opportunities to trial identifying a multi billion market potential.... and thats to say nothing of the support of a bunch of oh so lovely rusted on shareholders.
- Forums
- ASX - By Stock
- FDA Application for Orphan Drug Designation , PAA, MPL
"........... now discussing commercialization not weather or not...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
-0.015(6.25%) |
Mkt cap ! $109.4M |
Open | High | Low | Value | Volume |
24.0¢ | 24.0¢ | 22.5¢ | $133.9K | 573.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 303213 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 57592 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 258769 | 0.225 |
9 | 351041 | 0.220 |
2 | 26627 | 0.215 |
1 | 10000 | 0.210 |
3 | 101948 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 57592 | 2 |
0.240 | 20367 | 1 |
0.245 | 339236 | 4 |
0.250 | 306054 | 5 |
0.255 | 18631 | 2 |
Last trade - 15.46pm 18/10/2024 (20 minute delay) ? |
Featured News
LGP
Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
NUZ (ASX) Chart |